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Abstract Triple resonance 3D NMR methods have been used 
to study the interaction between caicineurin B and a peptide 
fragment of calcineurin A for which it has high affinity (K D 
~4 × 10 -7 M). Although calcineurin B aggregates at NMR 
concentrations of ~1 mM, in the presence of a target peptide 
fragment of caicineurin A it becomes monomeric and yields NMR 
spectra that are very similar to those reported previously for 
calcineurin B solubilized by the zwitterionic detergent CHAPS. 
Changes in chemical shifts between CHAPS- and peptide-solubil- 
ized calcineurin B are small which is indicative of no differences 
in secondary structure. Residues most affected by binding to 
target peptide are found primarily on the hydrophobic faces of the 
four helices, present in each of the two globular domains in cal- 
cineurin B, and in the loops connecting helices II and III, IV and 
V, and possibly in the C-terminal 12 residues, which also exhibit 
a change in mobility. 
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1. Introduction 
Calcineurin is a Ca 2+- and calmodulin-stimulated Ser/Thr- 
phosphatase, present in all eukaryotic ells, including nerve 
cells and T cells [1]. It consists of two tightly bound subunits, 
calcineurin A (CnA) and calcineurin B (CnB), with molecular 
masses of 59 and 19.3 kDa, respectively. CnA also binds to 
calmodulin. The two calcium-binding proteins, CnB and calm- 
odulin, are essential for the phosphatase activity of CnA [1]. 
Phosphatase activity is inhibited by the immunophilin-im- 
munosuppressant complexes FKBP-FK506 and cyclophilin-cy- 
closporin A [2 5]. Calcineurin plays a key role in activating T 
cells, and its inhibition blocks dephosphorylation f the cyto- 
plasmic subunit of the transcription factor NF-AT, NF-ATc, 
thereby blocking the transcription of cytokine genes and T cell 
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activation [6]. Cross-linking experiments between cyclophilin- 
cyclosporin A or FK506-FKBP and calcineurin (both A and 
B subunits) suggested that the immunophilin-immunosuppres- 
sant complexes interact primarily with the CnB subunit but 
only when bound to CnA [7]. However, subsequent mutagene- 
sis experiments showed that certain CnA mutants were capable 
of binding CnB, but these mutant complexes would not bind 
to immunophilin-drug complexes, casting some doubts on an 
exclusive CnB/immunophilin-drug interaction [8]. The struc- 
ture of the complex between CnA, CnB, FKBP and FK506 has 
been solved very recently by X-ray crystallography and con- 
firms that the FKBP-FK506 complex includes direct interac- 
tions with both the CnA and CnB subunits [9]. 
The amino acid sequence of CnB suggests the presence of 
four calcium-binding sites of the EF-hand helix-loop-helix 
(HLH) type [10] and these 12-residue sites are 54% identical 
with those in calmodulin; outside these calcium-binding sites 
the degree of sequence identity is only 20%. A recent NMR 
study confirms that the four calcium-binding sites are of the 
all-oxygen coordinating type and adopt a pentagonal bipyrami- 
dal geometry [11]. A previous triple resonance multidimen- 
sional NMR study of CnB, solubilized by the zwitterionic de- 
tergent CHAPS, indicated substantial structural homology 
with calmodulin, including the presence of eight s-helices, and 
a break in the 'central helix', similar to the one previously noted 
for calmodulin [12]. The length of the various helices was found 
to be substantially different, however. A modeling study also 
had suggested a similar structure for calmodulin and CnB [13]. 
The present report describes the results of an NMR study of 
the complex between genetically engineered CnB, lacking N- 
terminal myristoylation, and a 32-residue peptide fragment of 
CnA. This peptide fragment is one residue longer than the 
minimal peptide previously implicated in CnA binding [14] and 
7 residues horter at its C-terminus than the CnA sequence 
found to contact CnB in the crystal structure [9]. However, out 
of a large array of peptide fragments (H. Ren and C.B. Klee, 
to be published), the fragment used in the present study was the 
only one which yielded rotational diffusion consistent with a 
monomeric structure for the CnB-peptide complex at NMR 
concentrations. 
2. Materials and methods 
2.1. Sample preparation 
CnB was prepared and purified as described previously [15]. CnB was 
uniformly labeled with either ~SN (for ~SN-~H correlation) or both 15N 
and ~3C for triple resonance CBCA(CO)NH [16], CBCANH [17] and 
HNCA [18] experiments. The peptide P2465 (DDEQFNSSPH 
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PYWLPNFMDV FTWSLPFVGE KV) was synthesized by Peptide 
Technology (Gaithersburg, MD). The peptide was purified by HPLC 
and subsequently a Pharmacia G10 gel-filtration column, pre-equili- 
brated with 50 mM NH4HCO3, pH 5.0. A 1.5 mM aqueous olution 
of CnB containing 200 mM KCI, 0.04% NAN3, 11 mM CaCI2, 5% D20 , 
pH 5.8, was prepared. Solid peptide in a 1.1 : 1 molar ratio was added 
to the protein solution and the pH was readjusted to5.8. An additional 
15% molar excess of peptide was then added to ensure saturation of 
CnB with P2465. The sample was then dialyzed overnight using a 
collodion bag with a 10-kDa cut-off to remove xcess of peptide and 
the protein/peptide solution was concentrated to 1.5 mM. To reduce 
problems arising from evaporation and condensation f the solvent, 
caused by the relatively high temperature at which NMR spectra were 
recorded, a sample height of 5.2 cm was used and the part of the tube 
above the spinner was wrapped with foam insulation. 
2.2. NMR spectroscopy 
~SN-IH correlation spectra were measured at37, 42 and 47°C and the 
CBCA(CO)NH, CBCANH and HNCA spectra were recorded at 47 ° C. 
IHN T 2 relaxation times were measured on a Bruker DMX 500 MHz 
spectrometer and all other spectra were recorded on a Bruker AMX 600 
MHz spectrometer equipped with a triple resonance probehead and 
pulsed field gradients. Resonance assignments were based on three 
triple resonance experiments CBCA(CO)NH, CBCANH and HNCA, 
which all included pulsed field gradients and a WATERGATE scheme 
for suppression of the solvent signal [19]. The following number of 
complex points and acquisition times were used: 2D IH-~SN correlation 
(15N, F 0 256, 153.6 ms, (1H, F2) 1024, 110.6 ms; CBCA(CO)NH (13Ca- 
13C~, FI) 52, 6.2 ms, (15N, F2) 36, 22.3 ms, (IH, F3) 512, 55.3 ms; 
CBCANH (13C~-13CP, F 0 52, 6.2 ms, (lSN, F~) 36, 22.3 ms, (1H, F3) 512, 
55.3 ms; HNCA (~SN, FI) 34, 23.9 ms, (13C~, F2) 46, 11.04 ms, (JH, F3) 
512, 55.3 ms. Spectra were processed using the software package 
NMRPipe [20] and analysed using the programs PIPP and CAPP [21]. 
3. Results 
The P2465 peptide corresponds to residues 333 361 of the 
a-form of CnA, CnAa, and includes three additional acidic 
N-terminal residues for solubilization. Addition of stoichiomet- 
fie amounts of P2465 to CnB results in a remarkable improve- 
ment in the ~H NMR spectrum, as evidenced by a large increase 
in the T2 relaxation time of its amide protons. At 47°C, the use 
of substoichiometric amounts of peptide results in less line 
narrowing but the positions of the resolved resonances are not 
shifted towards those of the multimeric (aggregated) state. This 
indicates that the off-rate for the peptide is on the order of~ 100 
s -1. Its Kd was measured by sedimentation equilibrium to be 
4.3 x 10 -7 at 20°C (H. Ren and C. B. Klee, to be published). 
As reported previously, the mean T2 value for the downfield 
shifted amide protons is a convenient marker for the protein's 
rotational correlation time, re, and an empirical formula 
vc = 10 9/(5T2) S 2 has been proposed [22]. Using stoichiometric 
amounts of P2465, maximal Te values (in the 19-25 ms range) 
were obtained in CnB solutions containing 200 mM KC1 at pH 
5.9 and 47°C. At 37°C, T 2 values are in the 17-21 ms range, 
which compares to -11 ms for free CnB, and 20 ms in the 
presence of CHAPS. The 1H-15N HSQC [23] correlation spec- 
trum (Fig. 1) reveals that at temperatures lower than 47°C 
some of the amides have much shorter T2 values than others, 
indicative of conformational exchange on a micro- to millisec- 
ond time scale (vide infra) which becomes faster at higher tem- 
peratures. All multidimensional triple resonance xperiments 
therefore were carried out at 47°C and the complex was found 
to be stable at this temperature for the time needed to record 
all 3D NMR spectra. 
The sequential ssignment of the protein was accomplished 
using CBCA(CO)NH, CBCANH and HNCA spectra. In con- 
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Fig. 1. A section of the 600 MHz ~H-15N HSQC spectrum of CnB, 
complexed with the peptide P2465, recorded at 42°C. Residues with 
considerably weaker cross-peaks at42°C relative to their appearance 
at 47°C are labeled. The cross-peak of Q50 was not detected at 42°C 
and its position at 47°C is marked by parentheses. 
trast with our previous tudy of CnB [15], monomerized by 
CHAPS, the CBCA(CO)NH and the HNCA spectra for the 
CnB-peptide complex yielded cross-peaks for all but the N- 
terminal amino acid residue, allowing a complete sequential 
assignment. 
The deviations of the C a and C ~ chemical shifts from their 
random coil values are commonly used as markers for second- 
ary structure [25,26]. These deviations from random coil chem- 
ical shifts are presented inFig. 2. The changes in chemical shifts 
between the P2465-CnB complex and CHAPS-CnB are pre- 
sented in Fig. 3. These changes are smaller than, for example, 
the chemical shift changes observed in calmodulin upon com- 
plexation with its target peptide of myosin light chain kinase 
[24]. The absence of significant changes in C ~ and C ~ chemical 
shifts indicates that the secondary structure of CnB is the same 
in the CHAPS-monomerized form and in its complex with 
P2465. 
The effect of temperature on the 1HN and ~SN chemical shifts 
has been analysed by recording ~SN-1H SQC spectra t 37, 42 
and 47°C and chemical shift changes were found to be very 
small. These spectra lso revealed the presence of conforma- 
tional exchange on an intermediate ime scale (us-ms): The 
resonances of L45, Q49, N51, I58, D59, D62, M118, V132 and 
T135 are significantly weaker at 37°C compared to their inten- 
sity at 47°C; F81, V119 and V155 are much weaker, and E47, 
Q50 and V156 disappear altogether at 37°C. 
In CHAPS-CnB, the N-terminal residues (1-14), the C-termi- 
nal residues (158-169) and the linker connecting the two do- 
mains (residues 81-86) show increased mobility as judged by 
narrow, intense ~SN-~H cross-peaks and relatively fast amide 
proton exchange [15,27]. In CnB-P2465, only the N-terminus 
and the last three C-terminal residues retain this increased 
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Fig. 2. The ~3C~ and 13CP secondary shifts (A~3C ~and A~3C p) of CriB complexed with P 2465. The secondary structure, deduced from these deviations 
from random coil chemical shifts, and confirmed by ~H-IH NOEs in CHAPS-solubilized CnB, is also indicated. 
mobility. The segment connecting the two domains actually 
shows weaker-than-average correlations, indicating slow to in- 
termediate conformational exchange rates in this area. 
4. Discussion 
The small magnitude of the changes in chemical shifts of the 
CnB backbone and 13C~ nuclei indicate that CnB retains the 
same secondary structure upon binding to the CnA peptide. 
The small changes in chemical shifts that are observed are not 
localized to a small number of residues or short segments in the 
polypeptide sequence. However, residues in the four 12-residue 
calcium-binding sites are affected less than their adjacent he- 
lices and the loops connecting these helices. Chemical shift 
changes in helices VI and VII, and the loop connecting VI and 
VII also are smaller than average. The smaller-than-expected 
magnitude of the chemical shift changes upon complexation 
with P2465 may be due to the fact that the CnB-binding site was 
previously occupied by CHAPS, and that the change at the 
interaction interface is less dramatic than changing a solvent- 
exposed hydrophobic protein surface to one that interacts with 
a hydrophobic target peptide. In the present case, the chemical 
shift changes are therefore a less pronounced indicator for 
identifying the interaction surface. 
The X-ray crystal structure of calcineurin, complexed with 
FKBP and FK506 but not calmodulin, was solved very recently 
at a resolution of 2.5 A [9]. It is interesting to compare our 
NMR observations with this X-ray structure. The crystal struc- 
ture indicates a decrease in the CnB solvent accessible surface 
area by 1681 A 2. This is about twice the size of the contact area 
between lysozyme and its specific antibody [28]. This large 
contact area for a relatively small protein explains why the 
changes in chemical shifts are not limited to a small and well- 
defined region. 
The peptide used in our NMR study lacks seven C-terminal 
residues relative to the CnA helix interacting with CnB, and use 
of the full peptide does not yield monomeric behavior for the 
peptide-CnB complex. The above noted slow conformational 
exchange, affecting primarily the amides of residues 45-62 in 
CnB, may be caused by the fact that in the full complex this 
segment interacts with the residues that are missing in P2465. 
Similarly, residues M118 and V119, which are also subject o 
slow conformational veraging in the NMR spectra, interact 
with the FKBP-FK506 complex in the crystal structure. Indeed, 
in the absence of intermolecular interactions, the binding sites 
of proteins frequently experience increased conformational 
flexibility. For example, the backbone atoms of H87 through 
I90 of the FKBP-FK506 complex bound to calcineurin are 
reported to shift by 1 A. relative to the structure of the FKBP- 
FK506 complex alone [9]. The lowest heteronuclear 15N-IH 
NOE in the FKBP-FK506 complex is observed for H87, indic- 
ative of significant backbone motions occurring on a time scale 
of ~ 1 ns [29]. 
The previously mentioned ecrease in rapid large amplitude 
motions for CnB residues 81-86, which connect the N- and 
C-terminal domains, upon complexation with P2465 is con- 
sistent with the X-ray structure of the complex, in which this 
linker now interacts with the target peptide [9]. The C-terminal 
12 residues also lose their high degree of mobility upon peptide 
binding. In the X-ray structure, this C-terminus forms an ex- 
tended strand which lies parallel to the CnA helical target site 
and interacts with both CnA and CnB. Although such a confor- 
mation would explain the decrease in mobility observed for 
these residues, the chemical shift changes upon complexation 
of P2465 are smaller than expected for a change from a random 
coil to a fully extended conformation and it remains unclear 
whether this interaction actually occurs in the P2465-CnB com- 
plex or not. 
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Fig. 3. Plots of the change in chemical shift for ~H N, ~SN, a3C~ and 13Cfl, occurring upon complexation of CnB with P2465, relative to the values of 
CHAPS-CnB. The 'H N and tSN chemical shifts in both cases correspond to 37°C, whereas the ~3C~ and 13C~ shifts for the complex 
with P2465 correspond to 47°C. A complete table of ~H TM, ~SN, ~3C= and ~3Ca chemical shifts will be deposited with the BMRB data bank (Madison, 
WI). 
The CnB secondary structure, as identified from the devia- 
tions from random coil '3C~ and 13CP chemical shifts, is identical 
with that reported previously [15] and agrees quite well with 
that observed in the X-ray structure, except for some minor 
differences which presumably are largely semantic. For exam- 
ple, Griffith et al. [9] include $38 in helix II, whereas our NMR 
data identify this residue as the N-cap for this helix on the basis 
of its C a and C p chemical shifts [30]. The only minor discrepan- 
cies appear to be at the C-terminal end of helix II, which 
according to the NMR data extends to $44, and terminates at 
F42 according to the X-ray, and the last helix, VIII, which 
appears to be fraying and extends to G157 in the NMR data, 
but terminates at V155 in the X-ray definition. In both these 
instances, the chemical shifts of the two residues involved are 
112 J. Anglister et al./FEBS Letters 375 (1995) 108-112 
intermediate between helical and random coil values, and the 
difference in secondary structure is therefore unlikely to be 
significant. 
Comparison of the crystal structure of the calcineurin com- 
plex with our NMR study of CnB and its complex with P2465 
provides upport for two complementary approaches for stud- 
ying large intermolecular complexes by NMR. First, the deter- 
gent CHAPS indeed can reduce aggregation without perturbing 
the protein's tructure. Second, peptide fragments of the other 
subunit, even if considerably shorter than the full length that 
interacts with the protein of interest, can be used to alleviate 
aggregation problems encountered with the free subunit. 
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